APP Generic Cisplatin To Launch At 12.5% Discount To Bristol's Platinol AQ
American Pharmaceutical Partners' generic version of Bristol-Myers Squibb's Platinol AQ (cisplatin) will be launched at a 12.5% discount to the branded product, following a court decision declaring Bristol's patent invalid.
You may also be interested in...
The 180-day exclusivity for first generics cannot extend beyond the expiration of the patent challenged in the ANDA's paragraph IV certification, FDA said in granting exclusivity to American Pharmaceutical Partners for generic cisplatin even though it was not the first company to submit an ANDA for the drug.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials